National Prostate Cancer Audit: State of the Nation Report 2024
This report shows that Black men have higher rates of stage 3 and stage 4 prostate cancer diagnosis compared to white men, and Black men in their 60s who get a later diagnosis are also less likely to get NICE-approved treatment on the NHS.
PSA diagnostic case studies
Dr Sam Merriel and Dr Olly Hulson cover some case studies common to Primary Care, to explore early diagnosis and diagnostic pathways through real-world scenarios.
PSA consensus recommendations and implications for practice
Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Lived experience conversation
Meg Burgess, Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
The article reveals that Black men in England face significantly higher lifetime risks of prostate cancer diagnosis and mortality compared to White and Asian men, with the highest diagnosis and death rates among Black men, while mortality rates post-diagnosis are similar across ethnic groups.
The importance of real-world data in prostate cancer
Natalia Norori, Data & Evidence Manager at Prostate Cancer UK, helps us understand the importance of real- world data in prostate cancer.
Considerations for transgender and gender diverse patients with prostate cancer
Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.
Variation in harms and benefits of prostate-specific antigen screening for prostate cancer by socio-clinical risk factors: A rapid review
The article reviews PSA screening for prostate cancer, showing it improves detection of low-grade cancers and reduces advanced cases, especially in men aged 50-55 and those with a family history, but its long-term impact on mortality and ethnic risk needs further research.
